Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists dive deep into kidney tissue to uncover how diabetes drugs protect kidneys

NCT ID NCT07444203

First seen Mar 02, 2026 · Last updated May 23, 2026 · Updated 11 times

Summary

This study looks at kidney tissue from adults with diabetic kidney disease who are already scheduled for a kidney biopsy or surgery as part of their regular care. Researchers want to understand how SGLT2 inhibitors, a type of diabetes medicine, change the kidney's molecular fingerprint. By comparing people who take these drugs with those who don't, they hope to link these tissue changes to long-term kidney health. The study is observational, meaning no new treatments are given—just samples and medical records are analyzed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Penn Presbyterian Medical Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.